title: A prospective study: inflammation, infection and comorbidity in patients on long-term dialysis.
abstract: BACKGROUND
  The goal of this study was to identify inflammatory and infectious markers and their roles in mortality.
  
  
  METHODS
  We enrolled 111 patients on haemodialysis (HD) and collected data at three time points (baseline, 33 and 76 months).
  
  
  RESULTS
  Rates of Chlamydophila pneumoniae IgG, CRP ≥3 mg/l, ESR >50 mm/hour and fibrinogen >4 g/l were, respectively, 63.1%, 60.4%, 48.6% and 42.3%. Mortality was 21.6% and 43.2% at 33 and 76 months where 58.3% of all deaths were cardiocerebrovascular (CCV) related. Non-survivors were older than survivors. Univariate analysis showed diabetes mellitus (DM) and cerebrovascular accident (CVA) as important for the 33-month all-cause mortality, and CRPlog , fibrinogen, ESR >50 mm/hour, cardiovascular disease (CVD) and DM for the 76-month all-cause mortality. CVA was meaningful for the 33-month CCV mortality, and CVD, DM and ESR >50 mm/hour for the 76-month CCV mortality. Kaplan-Meier revealed poorer survival for patients with ESR >50 mm/hour at 76 months. Cox regression showed CVD, CVA and age as mortality predictors.
  
  
  CONCLUSIONS
  Age, CVD and CVA are predictors for mortality in patients on HD patients, but the presence of C. pneumoniae IgG and inflammation are not.
authors: Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, Turkey.
authors: Türkay
authors: T
authors: Akbaş
authors: Lütfiye
authors: L
authors: Mülazımoğlu
authors: Burak
authors: B
authors: Aksu
authors: Emel
authors: E
authors: Akoğlu
mesh_terms: D000368:Aged; D000907:Antibodies, Bacterial / Q000097:blood; D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000453:epidemiology; D023521:Chlamydophila Infections / Q000453:epidemiology*; D016993:Chlamydophila pneumoniae / Q000276:immunology / Q000302:isolation & purification*; D015897:Comorbidity; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007249:Inflammation / Q000453:epidemiology*; D007676:Kidney Failure, Chronic / Q000401:mortality* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011446:Prospective Studies; D006435:Renal Dialysis; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology; D016019:Survival Analysis
chemical_list: D000907:Antibodies, Bacterial; D015415:Biomarkers; D007074:Immunoglobulin G; D002097:C-Reactive Protein
keywords: C-reactive protein; Erythrocyte sedimentation rate; Fibrinogen; Haemodialysis; Seropositivity of C. pneumoniae IgG